Additionally, our previous work demonstrated that MPO inhibited tumor cell NF-κB signaling [31] and we anticipate that MPO could similarly inhibit NF-κB signaling in T cells, decreasing T cell activation. The gene discussed is MPO; the disease is neoplasm.